+772.1%
MRNA vs RF
+13.0%
+759.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RF | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -2.6% | +0.4% | -4.1% |
| 7D | -12.7% | -7.8% | -4.9% | -18.3% |
| 30D | -20.7% | -5.2% | -15.5% | -23.8% |
| 3M | +46.3% | -11.1% | +57.4% | +32.4% |
| 6M | +305.2% | -1.5% | +306.7% | +231.2% |
| YTD | +561.2% | +1.1% | +560.2% | +389.4% |
| 1Y | +772.1% | +14.8% | +757.3% | +508.9% |
| All | +772.1% | +13.0% | +759.1% | +508.9% |
Cumulative growth
Daily Returns
Daily percentage return beside RF.
Daily Out/Under-Performance
Portfolio return minus RF return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RF return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RF wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling